Welcome to BioMarket Group!

  • Home /
  • Publication Series

Publication Series

In this section you will find Publication Series market research reports and publications. These provide information on the latest products, news, market growth forecasts, data and business opportunities of value to your organization.

Items 1 to 15 of 9143 total

per page
Page:
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5

Set Ascending Direction

  1. Analytical Tool - Angiogenesis in Oncology

    $4,295.00
    Published by BioSeeker Group on Jan 30th, 2012
    The ultimate tool for serious players who would like to understand the current competitive field in cancer drug development among anti-angiogenic and vascular targeting agents. Learn More

  2. Triple Analysis: Colorectal Cancer, Melanoma and Apoptosis

    $4,495.00
    Published by BioSeeker Group on Dec 19th, 2011
    This triple analysis focuses on cancer drug development strategies in both Colorectal Cancer and Melanoma and by the mechanism/target/effect of Apoptosis. Learn More

  3. Triple Analysis: Breast Cancer, Apoptosis and Angiogenesis

    $4,495.00
    Published by BioSeeker Group on Dec 19th, 2011
    This triple analysis focuses on cancer drug development strategies in Breast Cancer and by the two mechanism/target/effect areas of Apoptosis and Angiogenesis. Learn More

  4. Triple Analysis: Apoptosis, Antibodies and Peptides

    $4,495.00
    Published by BioSeeker Group on Dec 19th, 2011
    This triple analysis focuses on cancer drug development strategies by the mechanism/target/effect of Apoptosis and by the two compound strategies of Antibodies and Peptides. Learn More

  5. Triple Analysis: Colorectal Cancer, Lung Cancer and Apoptosis

    $4,495.00
    Published by BioSeeker Group on Dec 19th, 2011
    This triple analysis focuses on cancer drug development strategies in both Colorectal Cancer and Lung Cancer and by the mechanism/target/effect of Apoptosis. Learn More

  6. Triple Analysis: Melanoma, Prostate Cancer and Apoptosis

    $4,495.00
    Published by BioSeeker Group on Dec 19th, 2011
    This triple analysis focuses on cancer drug development strategies in both Melanoma and Prostate Cancer and by the mechanism/target/effect of Apoptosis. Learn More

  7. Triple Analysis: Apoptosis, Protein Kinase Inhibitors and Antibodies

    $4,495.00
    Published by BioSeeker Group on Dec 19th, 2011
    This triple analysis focuses on cancer drug development strategies by the two mechanism/target/effect areas of Apoptosis and Protein Kinase Inhibitors and by the compound strategy of Antibodies. Learn More

  8. Triple Analysis: Lung Cancer, Prostate Cancer and Apoptosis

    $4,495.00
    Published by BioSeeker Group on Dec 19th, 2011
    This triple analysis focuses on cancer drug development strategies in both Lung Cancer and Prostate Cancer and by the mechanism/target/effect of Apoptosis. Learn More

  9. Triple Analysis: Breast Cancer, Melanoma and Apoptosis

    $4,495.00
    Published by BioSeeker Group on Dec 19th, 2011
    This triple analysis focuses on cancer drug development strategies in both Breast Cancer and Melanoma and by the mechanism/target/effect of Apoptosis. Learn More

  10. Triple Analysis: Colorectal Cancer, Prostate Cancer and Apoptosis

    $4,495.00
    Published by BioSeeker Group on Dec 19th, 2011
    This triple analysis focuses on cancer drug development strategies in both Colorectal Cancer and Prostate Cancer and by the mechanism/target/effect of Apoptosis. Learn More

  11. Triple Analysis: Lymphoma, Pancreatic Cancer and Apoptosis

    $4,495.00
    Published by BioSeeker Group on Dec 19th, 2011
    This triple analysis focuses on cancer drug development strategies in both Lymphoma and Pancreatic Cancer and by the mechanism/target/effect of Apoptosis. Learn More

  12. Triple Analysis: Breast Cancer, Lung Cancer and Apoptosis

    $4,495.00
    Published by BioSeeker Group on Dec 19th, 2011
    This triple analysis focuses on cancer drug development strategies in both Breast Cancer and Lung Cancer and by the mechanism/target/effect of Apoptosis. Learn More

  13. Triple Analysis: Pancreatic Cancer, Apoptosis and Antibodies

    $4,495.00
    Published by BioSeeker Group on Dec 19th, 2011
    This triple analysis focuses on cancer drug development strategies in one specific cancer indication (Pancreatic Cancer), one mechanism/target/effect area (Apoptosis) and one compound specific area (Antibodies). Learn More

  14. Triple Analysis: Leukemia, Lymphoma and Apoptosis

    $4,495.00
    Published by BioSeeker Group on Dec 19th, 2011
    This triple analysis focuses on cancer drug development strategies in both Leukemia and Lymphoma and by the mechanism/target/effect of Apoptosis. Learn More

  15. Triple Analysis: Apoptosis, Cancer Vaccines and Antibodies

    $4,495.00
    Published by BioSeeker Group on Dec 19th, 2011
    This triple analysis focuses on cancer drug development strategies by the two mechanism/target/effect areas of Apoptosis and Cancer Vaccines and by the compound strategy of Antibodies. Learn More

Items 1 to 15 of 9143 total

per page
Page:
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5

Set Ascending Direction

Publication Series

In this section you will find Publication Series market research reports and publications. These provide information on the latest products, news, market growth forecasts, data and business opportunities of value to your organization.

Items 1 to 15 of 9143 total

per page
Page:
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5

Set Ascending Direction

  1. Analytical Tool - Angiogenesis in Oncology

    $4,295.00
    Published by BioSeeker Group on Jan 30th, 2012
    The ultimate tool for serious players who would like to understand the current competitive field in cancer drug development among anti-angiogenic and vascular targeting agents. Learn More

  2. Triple Analysis: Colorectal Cancer, Melanoma and Apoptosis

    $4,495.00
    Published by BioSeeker Group on Dec 19th, 2011
    This triple analysis focuses on cancer drug development strategies in both Colorectal Cancer and Melanoma and by the mechanism/target/effect of Apoptosis. Learn More

  3. Triple Analysis: Breast Cancer, Apoptosis and Angiogenesis

    $4,495.00
    Published by BioSeeker Group on Dec 19th, 2011
    This triple analysis focuses on cancer drug development strategies in Breast Cancer and by the two mechanism/target/effect areas of Apoptosis and Angiogenesis. Learn More

  4. Triple Analysis: Apoptosis, Antibodies and Peptides

    $4,495.00
    Published by BioSeeker Group on Dec 19th, 2011
    This triple analysis focuses on cancer drug development strategies by the mechanism/target/effect of Apoptosis and by the two compound strategies of Antibodies and Peptides. Learn More

  5. Triple Analysis: Colorectal Cancer, Lung Cancer and Apoptosis

    $4,495.00
    Published by BioSeeker Group on Dec 19th, 2011
    This triple analysis focuses on cancer drug development strategies in both Colorectal Cancer and Lung Cancer and by the mechanism/target/effect of Apoptosis. Learn More

  6. Triple Analysis: Melanoma, Prostate Cancer and Apoptosis

    $4,495.00
    Published by BioSeeker Group on Dec 19th, 2011
    This triple analysis focuses on cancer drug development strategies in both Melanoma and Prostate Cancer and by the mechanism/target/effect of Apoptosis. Learn More

  7. Triple Analysis: Apoptosis, Protein Kinase Inhibitors and Antibodies

    $4,495.00
    Published by BioSeeker Group on Dec 19th, 2011
    This triple analysis focuses on cancer drug development strategies by the two mechanism/target/effect areas of Apoptosis and Protein Kinase Inhibitors and by the compound strategy of Antibodies. Learn More

  8. Triple Analysis: Lung Cancer, Prostate Cancer and Apoptosis

    $4,495.00
    Published by BioSeeker Group on Dec 19th, 2011
    This triple analysis focuses on cancer drug development strategies in both Lung Cancer and Prostate Cancer and by the mechanism/target/effect of Apoptosis. Learn More

  9. Triple Analysis: Breast Cancer, Melanoma and Apoptosis

    $4,495.00
    Published by BioSeeker Group on Dec 19th, 2011
    This triple analysis focuses on cancer drug development strategies in both Breast Cancer and Melanoma and by the mechanism/target/effect of Apoptosis. Learn More

  10. Triple Analysis: Colorectal Cancer, Prostate Cancer and Apoptosis

    $4,495.00
    Published by BioSeeker Group on Dec 19th, 2011
    This triple analysis focuses on cancer drug development strategies in both Colorectal Cancer and Prostate Cancer and by the mechanism/target/effect of Apoptosis. Learn More

  11. Triple Analysis: Lymphoma, Pancreatic Cancer and Apoptosis

    $4,495.00
    Published by BioSeeker Group on Dec 19th, 2011
    This triple analysis focuses on cancer drug development strategies in both Lymphoma and Pancreatic Cancer and by the mechanism/target/effect of Apoptosis. Learn More

  12. Triple Analysis: Breast Cancer, Lung Cancer and Apoptosis

    $4,495.00
    Published by BioSeeker Group on Dec 19th, 2011
    This triple analysis focuses on cancer drug development strategies in both Breast Cancer and Lung Cancer and by the mechanism/target/effect of Apoptosis. Learn More

  13. Triple Analysis: Pancreatic Cancer, Apoptosis and Antibodies

    $4,495.00
    Published by BioSeeker Group on Dec 19th, 2011
    This triple analysis focuses on cancer drug development strategies in one specific cancer indication (Pancreatic Cancer), one mechanism/target/effect area (Apoptosis) and one compound specific area (Antibodies). Learn More

  14. Triple Analysis: Leukemia, Lymphoma and Apoptosis

    $4,495.00
    Published by BioSeeker Group on Dec 19th, 2011
    This triple analysis focuses on cancer drug development strategies in both Leukemia and Lymphoma and by the mechanism/target/effect of Apoptosis. Learn More

  15. Triple Analysis: Apoptosis, Cancer Vaccines and Antibodies

    $4,495.00
    Published by BioSeeker Group on Dec 19th, 2011
    This triple analysis focuses on cancer drug development strategies by the two mechanism/target/effect areas of Apoptosis and Cancer Vaccines and by the compound strategy of Antibodies. Learn More

Items 1 to 15 of 9143 total

per page
Page:
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5

Set Ascending Direction
Shop By

Shopping Options

Category
  1. Analytical Tool (17)
  2. Commercial and Pipeline Insight (9)
  3. Commercial Insight (41)
  4. Deals & Alliances Reports (1686)
  5. Detailed Product Pipeline Reports (3373)
  6. Financial Markets Research (10)
  7. Pharma Partnering Guides (47)
  8. PharmaVitae (455)
  9. Pipeline and Commercial Insight (9)
  10. Pipeline Insight (57)
  11. Premium Company Profile (146)
  12. Private Company Reports (248)
  13. Spotlight Reports (1)
  14. Stakeholder Insight (63)
  15. Stakeholder Opinions (76)
  16. Therapeutic Competitor Reports (2907)
  17. Therapy Area Pipeline Reports (215)
Recently Viewed Products

  1. The CRO Market Outlook: Emerging markets, leading players and future trends

  2. Chinese Pharmaceutical Market Outlook 2009-2024

  3. OTC Pharmaceuticals in the Netherlands

  4. Pharmaceuticals: Germany Industry Guide

  5. Emerging Biotech Sector in Malaysia

My Cart

You have no items in your shopping cart.

Compare Products

You have no items to compare.

Newsletter

© BioMarket Group. All Rights Reserved.
BioSeeker Group and BioMarket Group are both trademarks of BioSeeker Group AB